You have full text access to this OnlineOpen article

Alimentary Pharmacology & Therapeutics

Cover image for Vol. 35 Issue 7

April 2012

Volume 35, Issue 7

Pages 745–864

  1. SYSTEMATIC REVIEW

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. You have full text access to this OnlineOpen article
      Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders (pages 745–767)

      J. Tack, M. Camilleri, L. Chang, W. D. Chey, J. J. Galligan, B. E. Lacy, S. Müller-Lissner, E. M. M. Quigley, J. Schuurkes, J. H. De Maeyer and V. Stanghellini

      Article first published online: 22 FEB 2012 | DOI: 10.1111/j.1365-2036.2012.05011.x

  2. REVIEW ARTICLE

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. You have free access to this content
      Review article: coeliac disease, new approaches to therapy (pages 768–781)

      S. Rashtak and J. A. Murray

      Article first published online: 13 FEB 2012 | DOI: 10.1111/j.1365-2036.2012.05013.x

  3. RANDOMISED CLINICAL TRIAL

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. You have full text access to this OnlineOpen article
      Randomised clinical trial: efficacy of a new synbiotic formulation containing Lactobacillus paracasei B21060 plus arabinogalactan and xilooligosaccharides in children with acute diarrhoea (pages 782–788)

      A. Passariello, G. Terrin, G. Cecere, M. Micillo, G. De Marco, M. Di Costanzo, L. Cosenza, L. Leone, R. Nocerino and R. Berni Canani

      Article first published online: 13 FEB 2012 | DOI: 10.1111/j.1365-2036.2012.05015.x

  4. NFLAMMATORY BOWEL DISEASE

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. You have full text access to this OnlineOpen article
      Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease (pages 789–795)

      A. N. Ananthakrishnan, R. Guzman-Perez, V. Gainer, T. Cai, S. Churchill, I. Kohane, R. M. Plenge and S. Murphy

      Article first published online: 23 FEB 2012 | DOI: 10.1111/j.1365-2036.2012.05022.x

  5. PEPTIC ULCER BLEEDING

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. You have full text access to this OnlineOpen article
      Chronic obstructive pulmonary disease: an independent risk factor for peptic ulcer bleeding: a nationwide population-based study (pages 796–802)

      K.-W. Huang, J.-C. Luo, H.-B. Leu, H.-C. Lin, F.-Y. Lee, W.-L. Chan, S.-J. Lin, J.-W. Chen and F.-Y. Chang

      Article first published online: 21 FEB 2012 | DOI: 10.1111/j.1365-2036.2012.05028.x

  6. BARRETT'S OESOPHAGUS

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. You have full text access to this OnlineOpen article
  7. ACID INHIBITION

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. You have full text access to this OnlineOpen article
      A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 polymorphism (pages 810–818)

      N. G. Hunfeld, D. J. Touw, R. A. Mathot, R. H. van Schaik and E. J. Kuipers

      Article first published online: 13 FEB 2012 | DOI: 10.1111/j.1365-2036.2012.05014.x

  8. NSAID MUCOSAL INJURY

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. You have full text access to this OnlineOpen article
      Endoscopic evaluation of the gastro-duodenal tolerance of short-term analgesic treatment with 25 mg diclofenac-K liquid capsules (pages 819–827)

      C. Hawkey, I. Burnett, M. S. Gold, K. Garsed, D. Stevenson, J. Mannath, A. Norman, V. Shepherd, V. Subramanian, R. D. Johnston and M. Brown

      Article first published online: 28 FEB 2012 | DOI: 10.1111/j.1365-2036.2012.05030.x

  9. IRRITABLE BOWEL SYNDROME

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. You have full text access to this OnlineOpen article
      Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome (pages 828–838)

      C. Chassard, M. Dapoigny, K. P. Scott, L. Crouzet, C. Del'homme, P. Marquet, J. C. Martin, G. Pickering, D. Ardid, A. Eschalier, C. Dubray, H. J. Flint and A. Bernalier-Donadille

      Article first published online: 8 FEB 2012 | DOI: 10.1111/j.1365-2036.2012.05007.x

  10. INVITED COMMENTARIES

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
    6. You have free access to this content
    7. You have free access to this content
    8. You have free access to this content
      Commentary: BMI and the need for adalimumab dose escalation in Crohn's disease (page 848)

      G. Van Assche, F. Baert and S. Vermeire

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05023.x

    9. You have free access to this content
    10. You have free access to this content
    11. You have free access to this content
  11. LETTERS TO THE EDITORS

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
      Letter: identication of probiotics by specific strain name (pages 859–860)

      R. Francavilla, C. Fontana and F. Cristofori

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05010.x

    6. You have free access to this content
    7. You have free access to this content
      Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation (pages 861–862)

      M. Saito, Y. Seo, Y. Yano, A. Miki, K. Momose, H. Hirano, M. Yoshida and T. Azuma

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05021.x

    8. You have free access to this content
  12. CORRIGENDA

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. You have free access to this content
      Corrigenda (page 864)

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05012.x

      This article corrects:
    2. You have free access to this content

SEARCH

SEARCH BY CITATION